결핵 진료지침
46. Wong SH, Gao Q, Tsoi KK, Wu WK, Tam LS, Lee N, et al. Effect of immunosuppressive therapy on interferon $\gamma$ release assay for latent tuberculosis screening in patients with autoimmune diseases: a systematic review and meta-analysis. Thorax 2016;71:64–72.
47. Falagas ME, Voidonikola PT, Angelousi AG. Tuberculosis in patients with systemic rheumatic or pulmonary diseases treated with glucocorticosteroids and the preventive role of isoniazid: a review of the available evidence. Int J Antimicrob Agents 2007;30:477–86.
48. World Health Organization. WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment 2020 [cited 2023 25th Jan]. Available from: https://www.who.int/publications/i/item/9789240001503.
49. National Institute for Health and Care Excellence. Tuberculosis, NICE guideline 2016 [cited 2023 25th Jan]. Available from: www.nice.org.uk/guidance/ng33.
50. Centers for Disease Control and Prevention. Latent Tuberculosis Infection: A Guide for Primary Health Care Providers 2020 [cited 2023 25th Jan]. Available from: https://www.cdc.gov/tb/publications/ltbi/.
51. Shu CC, Wei YF, Yeh YC, Lin HH, Chen CY, Wang PH, et al. The impact on incident tuberculosis by kidney function impairment status: analysis of severity relationship. Respir Res 2020;21:51.
52. Park S, Lee S, Kim Y, Lee Y, Kang MW, Cho S, et al. Association of CKD with Incident Tuberculosis. Clin J Am Soc Nephrol 2019;14:1002–10.
53. Grilo Novais A, Silva C, Coelho AR, Silva R, Carvalho AC. Rifampicin-induced Nephrotoxicity in a Tuberculosis Patient: Treatment Dilemma? Eur J Case Rep Intern Med 2021;8:002833.
54. World Health Organization. Global tuberculosis report 2021. 2021. p.
55. McAllister SM, Koesoemadinata RC, Santoso P, Soetedjo NNM, Kamil A, Per mana H, et al. High tuberculosis incidence among people living with diabetes in Indonesia. Trans R Soc Trop Med Hyg 2020;114:79–85.
56. Dobler CC, Cheung K, Nguyen J, Martin A. Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review

<PAGE>322
Ⅷ. 잠복결핵감염